Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 29.93B | 29.93B | 28.54B | 30.17B | 32.37B | 32.06B |
Gross Profit | 5.49B | 5.49B | 4.58B | 4.00B | 6.32B | 7.22B |
EBITDA | 2.94B | 3.46B | 2.60B | 1.95B | 4.25B | 5.16B |
Net Income | 1.48B | 1.48B | 820.48M | 310.65M | 2.06B | 2.62B |
Balance Sheet | ||||||
Total Assets | 30.41B | 30.41B | 29.72B | 31.07B | 32.42B | 27.96B |
Cash, Cash Equivalents and Short-Term Investments | 1.18B | 1.18B | 972.01M | 853.40M | 718.63M | 4.33B |
Total Debt | 1.49B | 1.49B | 2.21B | 4.33B | 808.15M | 555.36M |
Total Liabilities | 11.91B | 11.91B | 12.51B | 14.50B | 15.67B | 12.72B |
Stockholders Equity | 18.50B | 18.50B | 17.21B | 16.57B | 16.75B | 15.24B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 2.97B | 2.49B | -2.85B | -3.41B | 3.16B |
Operating Cash Flow | 0.00 | 4.37B | 3.63B | 1.48B | -1.33B | 5.22B |
Investing Cash Flow | 0.00 | -1.42B | -1.14B | -4.34B | -2.08B | -2.09B |
Financing Cash Flow | 0.00 | -997.00M | -2.39B | 3.00B | -273.53M | -680.45M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | ¥21.87B | 11.72 | 3.14% | 2.14% | -5.12% | ||
77 Outperform | ¥19.63B | 11.98 | 2.28% | 7.57% | 35.66% | ||
76 Outperform | ¥20.11B | 9.49 | 3.65% | 11.19% | 122.83% | ||
74 Outperform | ¥17.06B | 12.23 | 2.49% | 4.46% | 25.80% | ||
72 Outperform | ¥17.37B | 12.38 | 4.06% | 11.01% | 105.63% | ||
68 Neutral | ¥24.91B | 10.03 | 2.83% | -1.44% | -1.26% | ||
62 Neutral | $10.27B | 6.37 | 0.76% | 2.91% | 3.10% | -36.03% |
Taoka Chemical Co., Ltd. reported a significant increase in its financial performance for the three months ended June 30, 2025, with net sales rising by 12.6% and operating profit increasing by 45% compared to the same period last year. The company’s strong financial results indicate robust growth and improved profitability, which may enhance its competitive positioning in the chemical industry.
Taoka Chemical Co., Ltd. reported a significant increase in its financial performance for the quarter ending June 2025, with net sales rising by 12.6% and operating profit increasing by 45%. This growth reflects the company’s strong market positioning and operational efficiency, which could positively impact stakeholders and enhance its competitive edge in the chemical industry.